Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuraxis (NRXS) Invested Capital (2022 - 2025)

Neuraxis' Invested Capital history spans 4 years, with the latest figure at $3.4 million for Q4 2025.

  • On a quarterly basis, Invested Capital rose 64.4% to $3.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.4 million, a 64.4% increase, with the full-year FY2025 number at $3.4 million, up 64.4% from a year prior.
  • Invested Capital hit $3.4 million in Q4 2025 for Neuraxis, up from $2.3 million in the prior quarter.
  • Over the last five years, Invested Capital for NRXS hit a ceiling of $4.3 million in Q2 2025 and a floor of -$7.7 million in Q1 2023.
  • Historically, Invested Capital has averaged -$1.9 million across 4 years, with a median of -$1.8 million in 2024.
  • Biggest five-year swings in Invested Capital: plummeted 121.02% in 2023 and later surged 247.36% in 2024.
  • Tracing NRXS's Invested Capital over 4 years: stood at -$3.8 million in 2022, then soared by 63.44% to -$1.4 million in 2023, then surged by 247.36% to $2.1 million in 2024, then surged by 64.4% to $3.4 million in 2025.
  • Business Quant data shows Invested Capital for NRXS at $3.4 million in Q4 2025, $2.3 million in Q3 2025, and $4.3 million in Q2 2025.